Letter by Wong and Demers Regarding Article, “Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial”
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 4, 2023
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Benzhydryl Compounds (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Diabetes Mellitus, Type 2 (MeSH)
- Frailty (MeSH)
- Heart Failure (MeSH)
- Humans (MeSH)
- Hypoglycemic Agents (MeSH)
- Stroke Volume (MeSH)
published in
- Circulation Journal